Helen Louise Collins

Companies

• IO Biotech, Inc.Board member Nov 17, 2023 to now¹
• Enliven Therapeutics, Inc.Chief Medical Officer Feb 27, 2023 to now²
• Kura OncologyBoard member Jul 29, 2021 to now³
• Enliven Therapeutics, Inc.Board member Feb 27, 2023 to Feb 27, 2023⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• ETEnliven Therapeutics, Inc. ELVN25,000 shares⁵$958.2K at $38.33Sep 17, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 17, 2026Sold 240 shares at $51.48 of Enliven Therapeutics, Inc.⁵
• Sep 17, 2026Sold 1,844 shares at $50.71 of Enliven Therapeutics, Inc.⁵
• Sep 17, 2026Sold 2,916 shares at $50.03 of Enliven Therapeutics, Inc.⁵
• Sep 17, 2026Exercised options 5,000 shares at $2.48 of Enliven Therapeutics, Inc.⁵
• Aug 17, 2026Sold 1,100 shares at $59.35 of Enliven Therapeutics, Inc.⁶
• Aug 17, 2026Sold 3,900 shares at $58.37 of Enliven Therapeutics, Inc.⁶
• Aug 17, 2026Exercised options 5,000 shares at $2.48 of Enliven Therapeutics, Inc.⁶
• Jul 17, 2026Sold 63 shares at $53.92 of Enliven Therapeutics, Inc.⁷
• Jul 17, 2026Sold 2,184 shares at $53.42 of Enliven Therapeutics, Inc.⁷
• Jul 17, 2026Sold 2,063 shares at $52.39 of Enliven Therapeutics, Inc.⁷
• Jul 17, 2026Sold 459 shares at $51.55 of Enliven Therapeutics, Inc.⁷
• Jul 17, 2026Sold 231 shares at $50.05 of Enliven Therapeutics, Inc.⁷
• Jul 17, 2026Exercised options 5,000 shares at $2.48 of Enliven Therapeutics, Inc.⁷
• Jun 17, 2026Sold 1,133 shares at $44.74 of Enliven Therapeutics, Inc.⁸
• Jun 17, 2026Sold 2,599 shares at $43.87 of Enliven Therapeutics, Inc.⁸
• Jun 17, 2026Sold 1,268 shares at $42.83 of Enliven Therapeutics, Inc.⁸
• Jun 17, 2026Exercised options 5,000 shares at $2.48 of Enliven Therapeutics, Inc.⁸
• May 18, 2026Sold 223 shares at $41.21 of Enliven Therapeutics, Inc.⁹
• May 18, 2026Sold 1,302 shares at $40.25 of Enliven Therapeutics, Inc.⁹
• May 18, 2026Sold 3,475 shares at $39.53 of Enliven Therapeutics, Inc.⁹
• May 18, 2026Exercised options 5,000 shares at $2.48 of Enliven Therapeutics, Inc.⁹
• Apr 17, 2026Sold 2,441 shares at $48.06 of Enliven Therapeutics, Inc.¹⁰
• Apr 17, 2026Sold 2,419 shares at $47.39 of Enliven Therapeutics, Inc.¹⁰
• Apr 17, 2026Sold 140 shares at $45.81 of Enliven Therapeutics, Inc.¹⁰
• Apr 17, 2026Exercised options 5,000 shares at $2.48 of Enliven Therapeutics, Inc.¹⁰